@misc{indiciaea07ecb7eeec2,
  title = {Sorafenib, a clinically approved kinase inhibitor attenuates Streptococcus pneumoniae pathogenesis in vivo by targeting serine/threonine kinase StkP},
  author = {Abraham, J. and Sagilkumar, A. C. and Dhyani, H. and Panchal, C. M. and Aziz, S. and K, P. M. and Ruth, A. and Bhaskaran, K. and Chandrika, S. K. and Varghese, R. and Neeravi, A. and Veeraraghavan, B. and Ganesan, S. and Subramanian, K.},
  year = {2025},
  doi = {10.1101/2025.08.14.670243},
  url = {https://www.biorxiv.org/content/10.1101/2025.08.14.670243v1},
  note = {Source identifier: 10.1101/2025.08.14.670243}
}